Non-Alcoholic Steatohepatitis Biomarkers Market Demand, Size, Share, Key Players, Segments, Dynamics, Growth Rate and Forecast to 2023
Sep 6, 2019
Market Research Future (MRFR) Conducted An Elaborate Study On the Global Non-Alcoholic Steatohepatitis Biomarkers Market that predicts the growth of the market with a substantial 20.92% CAGR during the forecast period of 2019-2024.
Pune, India - September 5, 2019 /MarketersMedia/ —
key players in the global non-alcoholic steatohepatitis biomarkers market that includes are BioPredictive (France), Celerion (US), Cisbio (France), Echosens (France), Enterome (France), GENFIT (France), Laboratory Corporation of America Holdings (US), NGM Biopharmaceuticals (US), One Way Liver, SL (Spain), Pacific Biomarkers (US), Prometheus Laboratories Inc (US), Perspectrum Diagnostics Ltd (UK), Quest Diagnostics, Regulus Therapeutics, Inc. (US), Siemens Healthineers (Germany), Shenzhen New Industries Biomedical Engineering Co., Ltd (China), and Xeptagen SpA (Italy).
Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/7984
Market Overview:
The Global Non-Alcoholic Steatohepatitis Biomarkers Market is Expected to Register a CAGR of 20.92% and is Anticipated to Reach USD 1,960.4 Million by 2024. Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD), which is characterized by liver inflammation and damage caused by a buildup of fat in the liver. Currently, there are no noninvasive diagnostic tools approved for non-alcoholic steatohepatitis.
Growing prevalence of NASH, increasing demand for non-invasive diagnostic tests, and rising initiatives for creating awareness are some major factors propelling the growth of the market. Additionally, the rising prevalence of diabetes and obesity is likely to support market growth. On the hand, the presence of stringent regulations by the US FDA for the qualification of biomarkers is anticipated to restrict the market growth during the assessment period.
Market Segmentation
The global non-alcoholic steatohepatitis biomarkers market has been segmented by into type and end user. By type, the market has been segmented into serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers, and others. By end user, the market has been segmented into pharmaceutical companies and CROs, research institutes and academics, hospitals & clinics, diagnostic centers, and others.
Global Non-Alcoholic Steatohepatitis Biomarkers Market - Regional Analysis
Geographically, the Americas is expected to dominate the global non-alcoholic steatohepatitis biomarkers market. The growth in this region can be attributed to the favorable government initiatives, the presence of sophisticated healthcare infrastructure, and rising prevalence of diabetes, fatty liver disease, and obesity. Europe is anticipated to hold the second position in the global market owing to the factors such as growing incidence of NASH, increasing prevalence of obesity and diabetics, and increasing research and development on liver diseases. In the Asia-Pacific region, the market growth is mainly due to the factors such as the presence of a large patient base, increase in healthcare spending, and availability of skilled healthcare personnel. The Middle East and Africa is anticipated to register the lowest share in the global market. In the African region, the market is likely to be negatively affected by factors such as poor healthcare infrastructure, less disposable income, limited awareness about liver diseases, including NASH.
TOC:
1 Executive Summary$ 1,350.00
2 Market Introduction$ 0.00
3 Research Methodology$ 0.00
4 Market Dynamics$ 950.00
5 Market Factor Analysis$ 950.00
6 Global Non-Alcoholic Steatohepatitis Biomarkers Market, by Type$ 1,650.00
7 Global Non-Alcoholic Steatohepatitis Biomarkers Market, by End User$ 1,650.00
8 Global Non-Alcoholic Steatohepatitis Biomarkers Market, by Region$ 1,650.00
9 Competitive Landscape$ 1,050.00
10 Company Profiles
Continued…
Browse more Information on This Report at https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: 6468459312
Website: https://www.marketresearchfuture.com/reports/non-alcoholic-steatohepatitis-biomarkers-market-7984
Source: MarketersMedia
Release ID: 88915893
More News
Manipur HC puts census in state on hold till April 30, 2027
The Manipur High Court has kept the Census 2027 exercise in the state on hold until April 30, 2027, amid concerns over the prevailing situation. It directed the Registrar General and Census Commissioner to examine seven representations, including demands linked to the National Register of Citizens (NRC), and issue a reasoned order by the deadline.
Mars and Jupiter converge this weekend, but fireballs after dark could steal the show first
Mars and Jupiter converge in the eastern sky before sunrise on November 15 and appear especially close the following morning.Both events are visible without a telescope, but they call for different viewing times.
Mumbai and Thane authorities ground aerial firecrackers after Diwali blazes
Authorities in Mumbai and Thane implemented a ban on aerial firecrackers following a significant rise in fire incidents. Reports indicate that the Mumbai Fire Brigade responded to numerous fire calls, primarily due to firecrackers. This ban aims to prevent fire hazards, especially from falling embers onto flammable materials. Violators of the ban may face legal consequences under the Disaster Management Act.
US stock market stages massive rally today, adds $1.5 trillion: 5 reasons why Dow Jones, S&P 500 and Nasdaq surge as AMD and Tesla jump while Nvidia sinks
US stock market rally today: Wall Street added $1.5 trillion in market value on Monday as technology and semiconductor stocks recovered from last week's sell-off. The Dow Jones jumped more than 1,000 points, the S&P 500 gained 2.17%, and the Nasdaq rose 2.51%. AMD and Tesla led major stock gains, but Nvidia fell nearly 5%
Nvidia pays for CEO Jensen Huang’s home security, travel, drivers and car expenses: How much does it cost to protect him and his family?
Nvidia reported nearly $4 million in security-related costs for CEO Jensen Huang in fiscal 2026. The disclosure covers residential protection, personal-travel security, consultation fees and driver services, but does not reveal how many guards protect his home. The filing comes as Nvidia investigates reports of an alleged foreign intelligence effort targeting its CEO.
'No ordinary CEO': Why the AI race cannot do without Nvidia's Jensen Huang
Nvidia CEO Jensen Huang’s influence extends beyond chip supply, making him a central figure in the global AI industry. The company’s dominance in AI processors, investments across the sector and Huang’s close control over its strategy have raised concerns about the risks of depending heavily on one executive.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.